💰 Cost in India
Cabergoline: ₹200–₹500 for 7-day course; freeze-all adds embryo storage costs; no significant additional cost otherwise
📊 Success Rate
Severe OHSS rate: <0.5% when GnRH agonist trigger + freeze-all protocol is used in high-risk patients
⏱️ Duration
Prevention protocol: applied throughout stimulation and for 7 days post-retrieval
📂 Category
💊 Treatments

What is OHSS Prevention?

💡 OHSS prevention uses pre-stimulation risk stratification (AMH, AFC, PCOS) and intra-cycle modifications: low-dose stimulation, close monitoring, GnRH agonist trigger, freeze-all strategy, and dopamine agonist (cabergoline). Severe OHSS can be reduced to <0.5% in high-risk patients with a comprehensive protocol.

OHSS prevention is the suite of clinical strategies used during IVF stimulation to identify high-risk patients and modify the protocol to prevent ovarian hyperstimulation syndrome. With appropriate risk stratification and preventive interventions, severe OHSS can be reduced to near zero.

🇮🇳 India Context: OHSS Prevention is widely assessed and treated across major Indian fertility centres including Chennai, Mumbai, Bangalore, Delhi, and Hyderabad.

What are the key characteristics of OHSS Prevention?

  • Risk stratification: AMH >3.0 ng/mL, AFC >20, PCOS, age <35, BMI <20, prior OHSS — all indicate high risk
  • Low-dose stimulation start: 100–150 IU/day for high-risk patients vs 225–450 IU/day standard protocol
  • Close monitoring: transvaginal ultrasound every 1–2 days from Day 6–8 to count follicles and adjust dose
  • Dose adjustment (coasting): gonadotropin dose reduced or held if E2 rises rapidly or >15 follicles develop
  • GnRH agonist trigger (instead of hCG): reduces OHSS risk by >90% — requires antagonist stimulation protocol
  • Freeze-all strategy: all embryos cryopreserved — eliminates late OHSS by removing endogenous hCG from early pregnancy
  • Dopamine agonist (cabergoline 0.5mg/day × 7 days post-trigger): reduces VEGF-mediated vascular permeability
  • Cycle cancellation: last resort if >25 mature follicles or E2 >5000 pg/mL — prevents life-threatening OHSS

How does OHSS Prevention work?

1
Pre-cycle: AFC and AMH measured to classify ovarian response risk and assign a tailored stimulation protocol
2
Low-dose stimulation started; monitoring begins Day 5–6 to track follicle count and growth trajectory
3
If excessive response (>15 follicles <14mm by Day 8): dose reduced; antagonist started earlier
4
GnRH agonist trigger given instead of hCG when follicles are mature — shorter LH surge, less VEGF stimulation
5
Cabergoline started on day of trigger in high-risk patients — reduces vascular permeability for 7 days post-retrieval
6
Freeze-all decision: all embryos cryopreserved; no fresh transfer — eliminates late OHSS from endogenous hCG

Why does OHSS Prevention matter in fertility?

OHSS prevention does not compromise IVF outcomes. GnRH agonist trigger combined with freeze-all produces equivalent or superior live birth rates to fresh transfer in high-risk patients — while reducing severe OHSS to near zero. The most impactful single intervention is freeze-all: removing the embryo from the OHSS-risk environment entirely. Cabergoline and individualised dosing are adjuncts. In India, OHSS prevention protocols are implemented at all NABH-accredited IVF centres as a mandatory safety standard; patients at high risk should be explicitly counselled before stimulation begins.

FAQs about OHSS Prevention

How is OHSS prevented in IVF?

OHSS is prevented through: pre-cycle risk stratification (AMH, AFC, PCOS), low-dose stimulation start (100–150 IU/day), close monitoring, GnRH agonist trigger (instead of hCG), freeze-all strategy, and cabergoline (0.5mg/day × 7 days). Severe OHSS can be reduced to near zero with this protocol.

What is a GnRH agonist trigger and why does it prevent OHSS?

GnRH agonist trigger replaces the standard hCG trigger shot. It causes a shorter, physiological LH surge that induces final oocyte maturation with significantly less VEGF stimulation — reducing OHSS risk by >90%. It requires an antagonist stimulation protocol and must be paired with freeze-all for optimal outcomes.

What is freeze-all and how does it prevent OHSS?

Freeze-all means cryopreserving all embryos and performing no fresh transfer. It prevents late OHSS by eliminating endogenous hCG from early pregnancy — the main driver of prolonged, severe late OHSS. All frozen embryos are transferred in a subsequent natural or medicated FET cycle after ovarian recovery.

What is cabergoline used for in IVF?

Cabergoline is a dopamine agonist given at 0.5mg/day for 7 days post-trigger in high-risk patients. It reduces VEGF-mediated vascular permeability — lowering fluid leakage without affecting egg quality. It is an adjunct to (not a replacement for) GnRH agonist trigger and freeze-all in OHSS prevention.

Can OHSS be prevented in PCOS patients undergoing IVF?

Yes. PCOS patients should receive low-dose stimulation (100 IU/day start), close monitoring from Day 5–6, GnRH agonist trigger, and freeze-all strategy. With this combined approach, severe OHSS in PCOS patients can be reduced to near zero without compromising IVF egg yield or embryo quality.

🏥 Find Specialists for OHSS Prevention in India

Connect with verified fertility specialists who can guide you through ohss prevention.

Medical Disclaimer: This page is for educational purposes only and does not constitute medical advice. Reviewed by Dr. Priya Sharma (MBBS, MD OB-GYN). Success rates and costs are approximate and vary by clinic and individual case. Always consult a qualified fertility specialist. Last updated: April 2026.